Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00114894 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevention of Jellyfish Stings

StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv7
  2. Lead sponsor: Boulware, David R, MD to University of Minnesotav6
  3. 2 versions Re-verified since Jun 2, 2020, no change to tracked fieldsv4-v5
  4. Primary completion date: Jan 2006 Completion date: Feb 2005 to Feb 2006 · Interventions: Safe Sea ™ (Drug) to Placebo (Other), Safe Sea ™ (Other) · Study arms: 0 to 2v3 Show 3 more changesShow less
    • Completion date: Feb 2005 to Feb 2006
    • Interventions: Safe Sea ™ (Drug) to Placebo (Other), Safe Sea ™ (Other)
    • Study arms: 0 to 2
  5. Interventions: Safe Sea (TM) (Drug) to Safe Sea ™ (Drug) Secondary endpoints: details revised at 2 of 2 entriesv2 Show 1 more changeShow less
    • Secondary endpoints: details revised at 2 of 2 entries
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Jellyfish stings are a common occurrence among ocean-goers worldwide with an estimated 150 million envenomations annually. Fatalities and hospitalizations occur annually, particularly in the Indo-Pacific regions. A new topical jellyfish sting inhibitor based on the mucous coating of the clown fish prevents 85% of jellyfish stings in laboratory settings. The field effectiveness is unknown. This is a field test to determine the real world effectiveness.
Trial Details
NCT Number NCT00114894
Lead Sponsor University of Minnesota
Conditions Bites and Stings
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov